Authors:
VENESMAA P
STENMAN UH
FORSS M
LEMINEN A
LEHTOVIRTA P
VARTIAINEN J
PAAVONEN J
Citation: P. Venesmaa et al., PREOPERATIVE SERUM LEVEL OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR AND RESIDUAL TUMOR SIZE AS PROGNOSTIC INDICATORS IN STAGE-III EPITHELIAL OVARIAN-CANCER, British journal of obstetrics and gynaecology, 105(5), 1998, pp. 508-511
Authors:
VENESMAA P
PAAVONEN J
FORSS M
YLIKORKALA O
Citation: P. Venesmaa et al., CHEMOTHERAPY CHANGES THE DNA-PLOIDY IN OVARIAN-CANCER, British journal of obstetrics and gynaecology, 102(7), 1995, pp. 568-569
Citation: A. Leminen et al., THERAPEUTIC AND PROGNOSTIC CONSIDERATIONS IN PRIMARY-CARCINOMA OF THEVAGINA, Acta obstetricia et gynecologica Scandinavica, 74(5), 1995, pp. 379-383
Citation: A. Leminen et al., ENDOMETRIAL ADENOCARCINOMA WITH CLINICAL-EVIDENCE OF CERVICAL INVOLVEMENT - ACCURACY OF DIAGNOSTIC PROCEDURES, CLINICAL COURSE, AND PROGNOSTIC FACTORS, Acta obstetricia et gynecologica Scandinavica, 74(1), 1995, pp. 61-66
Authors:
VENESMAA P
LEHTOVIRTA P
STENMAN UH
LEMINEN A
FORSS M
YLIKORKALA O
Citation: P. Venesmaa et al., TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) - COMPARISON WITH CA125 AS A PREOPERATIVE PROGNOSTIC INDICATOR IN ADVANCED OVARIAN-CANCER, British Journal of Cancer, 70(6), 1994, pp. 1188-1190